dc.contributor.author | Alhegazi, Sami Omar | |
dc.date.accessioned | 2020-07-07T10:21:46Z | |
dc.date.available | 2020-07-07T10:21:46Z | |
dc.date.issued | 2020-03-15 | |
dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/1748 | |
dc.description | Type 2 diabetes mellitus (T2DM) is currently extremely common due to the prevalence of obesity, as
well as the aging of the population.1 Prevention and treatment strategies for the classical
macrovascular and microvascular complications of diabetes mellitus have significantly improved.
Therefore, people are living longer with diabetes mellitus, which might lead to the emergence of new
complications. Dementia is one example of these emerging new complications.2 Compared with the
general population, the increased risk of dementia is 50%–150% in people with T2DM 3-5 Britch DM
center predicted that people living with dementia worldwide would increase from 35.6 million in
2010 to 115.4 million in 2050 | en_US |
dc.description.abstract | Epidemiological and basic science evidence suggest a possible shared pathophysiology between type
2 diabetes mellitus (T2DM) and Alzheimers disease (AD). It has even been hypothesized that AD
might be ‘type 3. We examined the association between diabetes-related factors and pathology of
Alzheimer disease (AD) to evaluate how diabetes affects the pathogenic process of AD .and how the
treatment of (AD) type 2 diabetes mellitus (T2DM) can affect on Alzheimers disease (AD) patients.
This study included specimens from a series of 135 autopsies of residents of the town of Hisayama in
Fukuoka prefecture (74 men and 61 women) performed between 1998 and 2003, who underwent a 75-
g oral glucose tolerance test in clinical examinations in 1988. We measured diabetes-related factors
including fasting glucose, 2-hour post-load plasma glucose, fasting insulin, and homeostasis model
assessment of insulin resistance (HOMA-IR) in 1988. . Neuritic plaques (NPs) were assessed
according to the Consortium to Establish a Registry for Alzheimer's Disease guidelines and
neurofibrillary tangles (NFTs) were assessed according to Break stage. The associations between each
factor and AD pathology were examined by analysis of covariance and logistic regression
analyses.Higher levels of 2-hour post-load plasma glucose, fasting insulin, and HOMA-IR were
associated with increased risk for NPs after adjustment for age, sex, systolic blood pressure, total
cholesterol, body mass index, habitual smoking, regular exercise, and cerebrovascular disease.
However, there were no relationships between diabetes-related factors and NFTs. Regarding the
effects of APOE genotype on the risk of AD pathology, the coexistence of hyperglycemia
and APOE ε4 increased the risk for NP formation. A similar enhancement was observed for
hyperinsulinemia and high HOMA-IR. The results of this study suggest that hyperinsulinemia and
hyperglycemia caused by insulin resistance accelerate NP formation in combination with the effects
of APOE ε4. The results of this study suggest that hyperinsulinemia and hyperglycemia caused by
insulin resistance accelerate NP formation in combination with the effects of APOE ε4. | en_US |
dc.language.iso | en | en_US |
dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | Antidiabetics drugs in treatments Alzheimer’s disease (AD) | en_US |
dc.type | Other | en_US |